EOE is a suspected infectious disease in the area of respiratory digestive and endocrine disorders, with complex clinical outcomes and often involving multi-system fatigue. Early identification and standardized diagnosis are critical to improving prognosis. The diagnosis of EOE requires a combination of clinical outcomes, imaging inspections, laboratory testing and pathological activation.
The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of EOE require individual development, usually including multidimensional management of pharmacological therapy, rehabilitation interventions, and regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of endocrine endocarditis (EOE). 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.